Wenyi Mei
Shanghai, 200062, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Pygenic Acid A, a Small-Molecule PD-1/SHP-2 Inhibitor, Enhances Efficacy of Therapeutic Melanoma Vaccines and Prophylactic Influenza Vaccines.
Journal: Virologica Sinica
Published: June 03, 2026
Discovery of 1,2-Diol TRPV4 Antagonists with Efficacy in a 3D Myocardial Fibrosis Organoid Model and a Murine TAC Pressure-Overload Model.
Journal: Journal of medicinal chemistry
Published: May 14, 2026
Direct Ser797 Interacted Pteridine-7(8H)-one Derivatives as Highly Selective and Orally Available EGFRL858R/T790M/C797S Inhibitors.
Journal: Journal of medicinal chemistry
Published: August 28, 2025
Discovery of Tamsulosin Derivatives with Shifted Selectivity from the α1-Adrenergic Receptor to ANO1 as Potent Antiosteoporotic Agents.
Journal: Journal of medicinal chemistry
Published: August 12, 2025
Exploring the macrocyclic chemical space for heuristic drug design with deep learning models.
Journal: Communications chemistry
Published: July 14, 2025
Design, Synthesis, and Biological Evaluation of Macrocyclic 2-Amino-4-phenylaminopyrimidine Derivatives as Potent JAK2 Inhibitors.
Journal: Journal of medicinal chemistry
Published: June 26, 2025
Discovery of a Proteolysis-Targeting Chimera Degrader of JAK2 as a Potential Therapeutic Agent for JAK2-Mediated Myeloproliferative Neoplasms.
Journal: Journal of medicinal chemistry
Published: June 03, 2025
Design, Synthesis, and Biological Evaluation of Pyrrolo[1,2-a]quinoxalin-4(5H)-one Derivatives as Potent and Orally Available Noncovalent Bruton's Tyrosine Kinase (BTK) Inhibitors.
Journal: Journal of medicinal chemistry
Published: April 07, 2025
Structure-based design of novel pyrrolo[1,2-a]quinoxalin-4(5H)-one derivatives as potent noncovalent Bruton's tyrosine kinase (BTK) inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: March 17, 2025
Correction to "Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73".
Journal: Journal of medicinal chemistry
Published: September 30, 2024
Design, synthesis, and biological evaluation of diphenyl ether substituted quinazolin-4-amine derivatives as potent EGFRL858R/T790M/C797S inhibitors.
Journal: European journal of medicinal chemistry
Published: July 17, 2024
Last Updated: 09/26/2026